About Chemcaps Limited
Data last updated: 09 January 2026
Chemcaps Limited is a public limited company based in New Delhi, Delhi, India. It specialises in medical consumables and supplies, a part of the broader healthcare sector. Incorporated on 18 June 1980, the company has been in operation for over 46 years.
Registered with ROC Delhi under CIN U51397DL1980PLC091361.
Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.35 Cr. It is led by directors including Arun Mittal and Preeti Saxena.
Last AGM: 26 September 2024. Financial statements filed for year ended 31 March 2024. Office: 205 Elite House 36 Community Kailash Colony Extension, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2023, the company reported a revenue of ₹25,641, a decline of 68.25% compared to the previous year.
The company is associated with 1 brand - Chemcaps. As per MCA filings, the company has satisfied charges of ₹2.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemcaps.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address205 Elite House 36 Community Kailash Colony Extension, New Delhi, Delhi, India – 110048
-
IndustryHealthcare, Medical Consumables & Supplies
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Chemcaps Limited
Chemcaps Limited has one previous CIN (Corporate Identification Number): L51397DL1980PLC091361. The current CIN is U51397DL1980PLC091361, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397DL1980PLC091361 | Current |
| L51397DL1980PLC091361 | Previous |
Associated Brands with Chemcaps Limited
Chemcaps Limited operates one associated brand: Chemcaps. These brands represent Chemcaps Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports empty hard gelatine capsules for global pharmaceutical industry needs. | chemcaps.com |
Competitors & Alternatives of Chemcaps Limited
Brands and companies operating in the same space as Chemcaps Limited include Encube Ethicals, Famar, Crown Laboratories and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Encube Ethicals
|
Contract development and manufacturing for topical semisolid formulations are provided. | Mumbai, India, India | 1998 |
Famar
|
Contract manufacturing and development services provider | Athens, Greece, Greece | 1949 |
Crown Laboratories
|
OTC, prescription, skin care, and oral care products are manufactured. | Johnson City, United States, United States | 2000 |
Formulated Solutions
|
Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors | Largo, United States, United States | 1999 |
Curida
|
Liquid pharmaceuticals are developed via blow fill seal technology. | Elverum, Norway, Norway | 2015 |
Chemineau Labs
|
CDMO specializing in ENT and topical dosage forms | Vouvray, France, France | 1947 |
Contract Pharmaceuticals
|
CDMO focused on manufacturing of semi-solid pharmaceutical drugs | Mississauga, Canada, Canada | 1991 |
Pharmasol
|
Pharmasol is recognized as a Contract Development and Manufacturing Organization. | Easton, United States, United States | 1996 |
Business Activity of Chemcaps Limited
Chemcaps Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Chemcaps Limited
Chemcaps Limited is audited by R. Verma & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R. Verma & Associates | blur-value | blur-value | blur-value |
Board of Directors of Chemcaps Limited
Chemcaps Limited is currently managed by 3 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Arun Mittal
Also directs:
Proderna Biotech Private Limited
|
Director | 18 Jun 1983 | 43 Years 0 Months | Current |
|
Preeti Saxena
Also directs:
Samtex Fashions Limited, Trulife Ventures Private Limited, Datasoft Computer Services Limited and 1 more
|
Director | 28 Apr 2023 | 3 Years 2 Months | Current |
|
Prem Chand Goel
Also directs:
Proderna Biotech Private Limited, Saurabh Textiles Pvt Ltd, Sovereign Autotech Private Limited and 1 more
|
Director | 18 Jun 1983 | 43 Years 0 Months | Current |
Financials of Chemcaps Limited FY 2024 filings available
Chemcaps Limited reported revenue of ₹- (down -68.25% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Chemcaps Limited
As of FY 2023, Chemcaps Limited's shareholding pattern shows 69.45% by promoters, 3.62% by domestic institutional investors (DII), 26.92% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Chemcaps Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2006 | State Bank of India | ₹2.2 Cr | Satisfied |
| 25 Oct 1996 | Oriental Bank of Commerce | ₹- | Satisfied |
| 25 Oct 1996 | Oriental Bank of Commerce | ₹- | Satisfied |
| 25 Oct 1996 | Oriental Bank of Commerce | ₹- | Satisfied |
| 28 Dec 1989 | Oriental Bank of Commerce | ₹- | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Chemcaps Limited
View historical data on people associated with Chemcaps Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Chemcaps Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Chemcaps Limited
GSTIN & GST Filing Data of Chemcaps Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Chemcaps Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Chemcaps Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Chemcaps Limited
MSME Payment Delays by Chemcaps Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Chemcaps Limited
Subsidiaries & Group Companies of Chemcaps Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Chemcaps Limited with ownership details.
MCA Filings & Documents of Chemcaps Limited
MCA Filings & Documents of Chemcaps Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Chemcaps Limited
Frequently Asked Questions about Chemcaps Limited
Chemcaps Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 18 June 1980 (46+ years old) and is registered under CIN U51397DL1980PLC091361.
Chemcaps Limited reported revenue of ₹25,641 for FY 2023 (down 68.25% YoY).
The current directors of Chemcaps Limited are:
The primary industry of Chemcaps Limited is healthcare. The company specifically operates in medical consumables and supplies. The company is currently active in this sector.
Chemcaps Limited can be reached at the registered office: 205 Elite House 36 Community Kailash Colony Extension, New Delhi, Delhi, India – 110048, or through the website chemcaps.com.
The authorised capital is ₹2 Cr, and the paid-up capital is ₹1.35 Cr.